ALSUntangled No. 50: Antifungal Therapy

References

• http://www.alsuntangled.com/open.php. Accessed March 2, 2019. Available at: http://www.webcitation.org/76Zpiz081.
   Google Scholar
• Lai G, Tan T, Pavelka N. The mammalian mycobiome: a complex system in a dynamic relationship with the host. Wiley Interdiscip Rev Syst Biol Med. 2019;11:e1438.
   PubMed Web of Science ®Google Scholar
• Reid WK, Inventor. Treatment of motor neuron disease, including certain neurological disorders, motor neuropathies and chronic inflammatory diseases. WO 2008/021970. 2008. Available at: http://www.webcitation.org/77mFajeKa. Accessed February 21, 2008.
   Google Scholar
• Reid W. Immunosuppression & mycotoxins causing amyotrophic lateral sclerosis. The winnower. 2017. Available at: http://www.webcitation.org/76MCrRWq0.
   Google Scholar
• French P, Ludowyke R, Guillemin G. Fungal neurotoxins and sporadic amyotrophic lateral sclerosis. Neurotox Res. 2018;35:969–80.
   PubMed Web of Science ®Google Scholar
• Castanedo-Vazquez D, Bosque-Varela P, Sainz-Pelayo A, Riancho J. Infectious agents and amyotrophic lateral sclerosis: another piece of the puzzle of motor neuron degeneration. J Neurol. 2019;266:27–36.
   PubMed Web of Science ®Google Scholar
• Forbes J, Bernstein C, Tremlett H, Van Domselaar G, Knox N. A fungal world: could the gut mycobiome be involved in neurological disease? Front Microbiol. 2019;9:3249.
   PubMed Web of Science ®Google Scholar
• Stott K, Hope W. Pharmacokinetics-pharmacodynamics of antifungal agents in the central nervous system. Expert Opin Drug Metab Toxicol. 2018;14:803–15.
   PubMed Web of Science ®Google Scholar
• Chen X, Feng W, Huang R, Guo X, Chen Y, Zheng Z. Evidence for peripheral immune activation in amyotrophic lateral sclerosis. J Neurol Sci. 2014;347:90–5.
   PubMed Web of Science ®Google Scholar
• Rentzos M, Evangelopoulos ME, Sereti E, Zouvelou V, Marmara S, Alexakis T, et al. Humoral immune activation in amyotrophic lateral sclerosis patients. Neurol Int. 2013;5:3.
   PubMedGoogle Scholar
• Lyon M, Wosiski-Kuhn M, Gillespie R, Caress J. Inflammation, immunity, and amyotrophic lateral sclerosis: I. Etiology and pathology. Muscle Nerve. 2019;59:10–22.
   PubMed Web of Science ®Google Scholar
• Alonso R, Pisa D, Marina AI, Morato E, Rábano A, Rodal I, et al. Evidence for fungal infection in cerebrospinal fluid and brain tissue from patients with amyotrophic lateral sclerosis. Int J Biol Sci. 2015;11:546–58.
   PubMed Web of Science ®Google Scholar
• Pisa D, Alonso R, Rabano A, Carrasco L. Corpora amylacea of brain tissue from neurodegenerative diseases are stained with specific antifungal antibodies. Front Neurosci. 2016;10:86.
   PubMed Web of Science ®Google Scholar
• Alonso R, Pisa D, Fernandez-Fernandez A, Rabano A, Carrasco L. Fungal infection in neural tissue of patients with amyotrophic lateral sclerosis. Neurobiol Dis. 2017;108:249–60.
   PubMed Web of Science ®Google Scholar
• Alonso R, Pisa D, Marina A, Morato E, Rabano A, Carrasco L. Fungal infection in patients with Alzheimer’s disease. J Alzheimers Dis. 2014;41:301–11.
   PubMed Web of Science ®Google Scholar
• Alonso R, Pisa D, Rabano A, Carrasco L. Alzheimer’s disease and disseminated mycoses. Eur J Clin Microbiol Infect Dis. 2014;33:1125–32.
   PubMed Web of Science ®Google Scholar
• Pisa D, Alonso R, Juarranz A, Rabano A, Carrasco L. Direct visualization of fungal infection in brains from patients with Alzheimer’s disease. J Alzheimers Dis. 2015;43:613–24.
   PubMed Web of Science ®Google Scholar
• Pisa D, Alonso R, Rabano A, Rodal I, Carrasco L. Different brain regions are infected with fungi in Alzheimer’s disease. Sci Rep. 2015;5:15015.
   PubMed Web of Science ®Google Scholar
• Alonso R, Pisa D, Rabano A, Rodal I, Carrasco L. Cerebrospinal fluid from Alzheimer’s disease patients contains fungal proteins and DNA. J Alzheimers Dis. 2015;47:873–6.
   PubMed Web of Science ®Google Scholar
• Pisa D, Alonso R, Horst M, Carrasco L. Fungal enolase, b-tubulin, and chitin are detected in brain tissue from Alzheimer’s disease patients. Front Microbiol. 2016;7:1772.
   PubMed Web of Science ®Google Scholar
• Alonso R, Pisa D, Aguado B, Carrasco L. Identification of fungal species in brain tissue from Alzheimer’s disease by next-generation sequencing. J Alzheimers Dis. 2017;58:55–67.
   PubMed Web of Science ®Google Scholar
• Alonso R, Pisa D, Fernandez-Fernandez A, Carrasco L. Infection of fungi and bacteria in brain tissue from elderly persons and patients With Alzheimer’s disease. Front Aging Neurosci. 2018;10:159.
   PubMed Web of Science ®Google Scholar
• Pisa D, Alonso R, Jimenez-Jimenez F, Carrasco L. Fungal infection in cerebrospinal fluid from some patients with multiple sclerosis. Eur J Clin Microbiol Infect Dis. 2013;32:795–801.
   PubMed Web of Science ®Google Scholar
• Alonso R, Fernandez-Fernandez A, Pisa D, Carrasco L. Multiple sclerosis and mixed microbial infections. Direct identification of fungi and bacteria in nervous tissue. Neurobiol Dis. 2018;117:42–61.
   PubMed Web of Science ®Google Scholar
• Lluch J, Servant F, Païssé S, Valle C, Valière S, Kuchly C, et al. The characterization of novel tissue microbiota using an optimized 16S metagenomic sequencing pipeline. PLoS One. 2015;10:e0142334.
   PubMed Web of Science ®Google Scholar
• Branton WG, Ellestad KK, Maingat F, Wheatley BM, Rud E, Warren RL, et al. Brain microbial populations in HIV/AIDS: a-proteobacteria predominate independent of host immune status. PLoS One. 2013;8:e54673.
   PubMed Web of Science ®Google Scholar
• Branton W, Lu J, Surette M, Holt RA, Lind J, Laman JD, Power C. Brain microbiota disruption within inflammatory demyelinating lesions in multiple sclerosis. Sci Rep. 2016;6:37344.
   PubMed Web of Science ®Google Scholar
• Emery D, Shoemark D, Batstone T, Waterfall C, Coghill JA, Cerajewska TL, et al. 16S rRNA next generation sequencing analysis shows bacteria in Alzheimer’s post-mortem brain. Front Aging Neurosci. 2017;9:195.
   PubMed Web of Science ®Google Scholar
• Jefferson R. Mapping the brain’s microbiome: can studying germs in the brain lead to a cure for Alzheimer’s? Forbes. 2017. Available at: http://www.webcitation.org/76QieaoQr. Accessed July 28, 2017.
   Google Scholar
• Servick K. Do gut bacteria make a second home in our brains? Science magazine. 2018. Available at: http://www.webcitation.org/76QikurcD. Accessed November 9, 2018.
   Google Scholar
• Molecular Biology of Neurodegeneration Laboratory. Is there a brain microbiome? University of Colorado Boulder. Available at: http://www.webcitation.org/76Qj1fYWI. Accessed November 9, 2018.
   Google Scholar
• Bedlack RS, Vaughan T, Wicks P, Heywood J, Sinani E, Selsov R, et al. How common are ALS plateaus and reversals? Neurology. 2016;86:808–12.
   PubMed Web of Science ®Google Scholar
• Olarte M, Schoenfeldt R, McKiernan G, Rowland L. Plasmapheresis in amyotrophic lateral sclerosis. Ann Neurol. 1980;8:644–5.
   PubMed Web of Science ®Google Scholar
• Kelemen J, Hedlund W, Orlin J, Berkman E, Munsat T. Plasmapheresis with immunosuppression in amyotrophic lateral sclerosis. Arch Neurol. 1983;40:752–3.
   PubMed Web of Science ®Google Scholar
• Monstad I, Dale I, Petlund F, Sjaastad O. Plasma exchange in motor neuron disease. A controlled study. J Neurol. 1979;221:59–66.
   PubMed Web of Science ®Google Scholar
• Silani V, Scarlato G, Valli G, Marconi M. Plasma exchange ineffective in amyotrophic lateral sclerosis. Arch Neurol. 1980;37:511–3.
   PubMed Web of Science ®Google Scholar
• Meucci N, Nobile-Orazio E, Scarlato G. Intravenous immunoglobulin therapy in amyotrophic lateral sclerosis. J Neurol. 1996;243:117–20.
   PubMed Web of Science ®Google Scholar
• Dalakas M, Stein D, Otero C, Sekul E, Cupler E, McCrosky S. Effect of high-dose intravenous immunoglobulin on amyotrophic lateral sclerosis and multifocal motor neuropathy. Arch Neurol. 1994;51:861–4.
   PubMed Web of Science ®Google Scholar
• Goralska K, Blaszkowska J, Dzikowiec M. Neuroinfections caused by fungi. Infection. 2018;46:443–59.
   PubMed Web of Science ®Google Scholar
• Pappas P, Kauffman C, Andes D, Clancy C, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;62:e1–e50.
   PubMed Web of Science ®Google Scholar
• Arendrup MC, Boekhout T, Akova M, Meis JF, Cornely OA, Lortholary O, et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections. Clin Microbiol Infect. 2014;20:76–98.
   PubMed Web of Science ®Google Scholar
• Yang H, Chaudhari P, Zhou ZY, Wu EQ, Patel C, Horn DL, et al. Budget impact analysis of liposomal amphotericin B and amphotericin B lipid complex in the treatment of invasive fungal infections in the United States. Appl Health Econ Health Policy. 2014;12:85–93.
   PubMedGoogle Scholar
• https://www.goodrx.com/fluconazole. Accessed February 28, 2019.
   Google Scholar
• https://www.goodrx.com/voriconazole. Accessed February 25, 2019.
   Google Scholar
• Girois S, Chapuis F, Decullier E, Revol B. Adverse effects of antifungal therapies in invasive fungal infections: review and meta-analysis. Eur J Clin Microbiol Infect Dis. 2006;25:138–49.
   PubMed Web of Science ®Google Scholar
• AmBisome [package insert]. San Dimas, CA: Gilead Sciences Inc.; 2018.
   Google Scholar
• Diflucan [package insert]. New York, NY: Pfizer Inc.; 2019.
   Google Scholar
• Vfend [package insert]. New York, NY: Pfizer Inc.; 2019.
   Google Scholar
• Malani A, Kerr L, Kauffman C. Voriconazole: how to use this antifungal agent and what to expect. Semin Respir Crit Care Med. 2015;36:786–95.
   PubMed Web of Science ®Google Scholar
• Levine M, Chandrasekar P. Adverse effects of voriconazole: over a decade of use. Clin Transplant. 2016;30:1377–86.
   PubMed Web of Science ®Google Scholar
• Kyriakidis I, Tragiannidis A, Munchen S, Groll A. Clinical hepatotoxicity associated with antifungal agents. Expert Opin Drug Saf. 2017;16:149–65.
   PubMed Web of Science ®Google Scholar
• Rilutek [package insert]. Bridgewater, NJ: Sanofi-Aventis U.S. LLC; 2012.
   Google Scholar
• Wanwimolruk S, Prachayasittikul V. Cytochrome P450 enzyme mediated herbal drug interactions (part 1). Excli J. 2014;13:347–91.
   PubMedGoogle Scholar
• Wanwimolruk S, Phopin K, Prachayasittikul V. Cytochrome P450 enzyme mediated herbal drug interactions (part 2). Excli J. 2014;13:869–96.
   PubMed Web of Science ®Google Scholar